Compare APC & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APC | PRME |
|---|---|---|
| Founded | 2025 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 819.0M | 666.1M |
| IPO Year | N/A | 2022 |
| Metric | APC | PRME |
|---|---|---|
| Price | $19.02 | $4.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 182.2K | ★ 2.5M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | N/A | $15.20 |
| Revenue Next Year | N/A | $316.23 |
| P/E Ratio | $25.80 | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $17.82 | $1.11 |
| 52 Week High | $19.80 | $6.94 |
| Indicator | APC | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 68.42 | 54.02 |
| Support Level | N/A | $3.19 |
| Resistance Level | $19.65 | $4.74 |
| Average True Range (ATR) | 0.63 | 0.28 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 57.58 | 56.68 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.